GE HealthCare Technologie... (GEHC)
62.40
0.92 (1.50%)
At close: Apr 17, 2025, 3:59 PM
61.93
-0.76%
After-hours: Apr 17, 2025, 07:42 PM EDT
1.50% (1D)
Bid | 61.36 |
Market Cap | 28.57B |
Revenue (ttm) | 19.67B |
Net Income (ttm) | 1.99B |
EPS (ttm) | 4.34 |
PE Ratio (ttm) | 14.38 |
Forward PE | 11.89 |
Analyst | Buy |
Ask | 62.94 |
Volume | 3,411,541 |
Avg. Volume (20D) | 3,948,039 |
Open | 62.00 |
Previous Close | 61.48 |
Day's Range | 61.70 - 62.84 |
52-Week Range | 57.65 - 94.80 |
Beta | 1.31 |
About GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. Th...
Sector Healthcare
IPO Date Dec 15, 2022
Employees 53,000
Stock Exchange NASDAQ
Ticker Symbol GEHC
Website https://www.gehealthcare.com
Analyst Forecast
According to 11 analyst ratings, the average rating for GEHC stock is "Buy." The 12-month stock price forecast is $102, which is an increase of 63.46% from the latest price.
Stock ForecastsNext Earnings Release
GE HealthCare Technologies Inc. is scheduled to release its earnings on Apr 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-15.96%
Shares of industrial stocks are trading lower amid...
Unlock content with
Pro Subscription
2 months ago
+8.82%
GE HealthCare Technologies shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results and issued FY25 adjusted EPS guidance with its midpoint above estimates.